Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
How can we unleash the potential of AI while managing the risks? Do we need to restrict powerful AIs to vetted experts? Global experts convened in Hong Kong to plot a safe future for AI.
Laboratory assessments — from preclinical research through post-marketing surveillance — determine whether a cell-based therapy for cancer succeeds or fails.
Hundreds of early- and mid-career scientists from around the world gathered in China for an exchange of ideas in late 2023. new research awards for sustainable development were a notable focus.
By bringing together scientists with a broad range of expertise, a high-risk, high-reward programme is seeking to deliver fault-tolerant quantum computers by 2050.
Biomarker-based diagnostics can detect the molecular changes associated with Alzheimer’s disease, and new updates to Medicare coverage could see these tests becoming much more common.
A new model to monitor the performance of phase change materials could boost heat transfer and optimize electricity production while reducing operational expenses of solar farms and nuclear plants.